1.
Gliclazide reduced oxidative stress, inflammation, and bone loss in an experimental periodontal disease model. J Appl Oral Sci [Internet]. 2019 Jun. 4 [cited 2024 May 6];27:e20180211. Available from: https://revistas.usp.br/jaos/article/view/158652